Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Parmar

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Molecular and Cellular Biology|August 1, 1993
Oncogenic activation of c-ABL by mutation within its last exonA Goga, J McLaughlin, A M Pendergast, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinaseA J Muller, A M Pendergast, K Parmar, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2005
Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimersJ Kelly, A Rudd, R R Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Randomised consent designs in cancer clinical trialsD G Altman, J Whitehead, M K Parmar, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Expression and functional characterization of the serine protease inhibitor neuroserpin in endocrine cellsRena M Hill, Leigh C Coates, Parmjeet K Parmar, et al.
Statistics in Medicine|September 15, 2000
Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working PartyW Qian, M K Parmar, R J Sambrook, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering CommitteeP Hopwood, A Harvey, J Davies, et al.
The Journal of Urology|April 21, 1999
Intravesical chemotherapy with epirubicin: a dose response studyJ R Masters, R J Popert, P M Thompson, et al.
The Biochemical Journal|January 22, 2000
Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cellsR M Hill, P K Parmar, L C Coates, et al.
British Journal of Urology|August 1, 1994
Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicinR J Popert, J Goodall, M J Coptcoat, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Molecular and Cellular Biology|August 1, 1993
Oncogenic activation of c-ABL by mutation within its last exonA Goga, J McLaughlin, A M Pendergast, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinaseA J Muller, A M Pendergast, K Parmar, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2005
Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimersJ Kelly, A Rudd, R R Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Randomised consent designs in cancer clinical trialsD G Altman, J Whitehead, M K Parmar, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Expression and functional characterization of the serine protease inhibitor neuroserpin in endocrine cellsRena M Hill, Leigh C Coates, Parmjeet K Parmar, et al.
Statistics in Medicine|September 15, 2000
Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working PartyW Qian, M K Parmar, R J Sambrook, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering CommitteeP Hopwood, A Harvey, J Davies, et al.
The Journal of Urology|April 21, 1999
Intravesical chemotherapy with epirubicin: a dose response studyJ R Masters, R J Popert, P M Thompson, et al.
The Biochemical Journal|January 22, 2000
Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cellsR M Hill, P K Parmar, L C Coates, et al.
British Journal of Urology|August 1, 1994
Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicinR J Popert, J Goodall, M J Coptcoat, et al.
Pageof 21